Skip to content
DataLookout
Menu

NCT06078527

Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort

StatusSuspended
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 10 versions: 10 with changes below. See every version on ClinicalTrials.gov ↗

  1. Stopped Trial status changed: Not Yet Recruiting → Suspended Sponsor's reason: Operational Show 6 more changesShow less
    • Phase changed: Not applicable → Not specified
    • Enrollment increased: 40 → 505 participants
    • Start date pushed from Nov 1, 2026 to Jun 30, 2027
    • Primary and study completion moved earlier from Jan 31, 2029 to Jun 30, 2028
    • Trial arms changed: 1 → 2
    • Site contact updated
  2. Notable Primary and study completion pushed from Jan 31, 2028 to Jan 31, 2029 Show 5 more changesShow less
    • Start date: Oct 1, 2025 to Nov 1, 2026
    • Eligibility criteria expanded, about 9 words
    • Primary endpoints: details revised at 1 of 2 entries
    • Secondary endpoints: details revised at 1 of 2 entries
    • Study description expanded, about 5 words
  3. Notable Primary and study completion dates: Jan 31, 2027 to Jan 31, 2028
    • Start date: Jun 1, 2025 to Oct 1, 2025
    v8
  4. Notable Start date: Apr 1, 2025 to Jun 1, 2025
    • Primary and study completion dates: Nov 30, 2026 to Jan 31, 2027
    v7
  5. Notable Start date: Feb 1, 2025 to Apr 1, 2025
    • Primary and study completion dates: Sep 30, 2026 to Nov 30, 2026
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Notable Primary and study completion dates: Mar 31, 2026 to Sep 30, 2026
    • Start date: Aug 1, 2024 to Feb 1, 2025
    • Site contact updated
    v5
  2. Notable Start date: Apr 30, 2024 to Aug 1, 2024
    • Primary and study completion dates: Jan 31, 2026 to Mar 31, 2026
    v4
  3. Notable Start date: Jan 31, 2024 to Apr 30, 2024
    • Primary and study completion dates: Nov 30, 2025 to Jan 31, 2026
    v3
  4. Notable Start date: Nov 1, 2023 to Jan 31, 2024v2
  1. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed

Endpoints

Primary

Percentage of participants with triggered/positive laryngeal adduction response (LAR)
Timeframe: 1 day
Median scores on the Penetration-Aspiration Scale (PAS)
Timeframe: 1 day

Secondary (2)

Median scores on the participant-reported laryngeal sensation (PRLS)
Percentage of participants with visualized laryngopharyngeal responses

Arms and interventions

Cancer Survivors

Participants will attend a single 15-30 minute study session during which they will answer questionnaires (5-10 minutes) and undergo laryngopharyngeal sensory testing (10-20 minutes). There will be up to 2 years of medical record follow up after completing the main study.

Healthy Controls

Participants will attend a single 15-30 minute study session during which they will answer questionnaires (5-10 minutes) and undergo laryngopharyngeal sensory testing (10-20 minutes). There will be up to 2 years of medical record follow up after completing the main study.

Devices: Cheung-Bearelly Aesthesiometer

Procedures: Transnasal Laryngoscopy

Other: Questionnaires

Sites

1 site in 1 country

  • University of California, San FranciscoSan Francisco, California, United States